Francesco Cosentino

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 36

Top Topics

Ankylosing Spondylitis

Glycemic Control

Thoracic Surgery

Top Venues

European heart journal

Diabetes/metabolism research and reviews

European heart journal. Cardiovascular pharmacotherapy

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Ayodele Odutayo, Francesco Cosentino, Richard E Pratley, Samuel Dagogo-Jack, Darren K McGuire, Robert Frederich, Wei Fu, Christopher P Cannon, David Z I Cherney, null null
Hypoglycaemia and kidney events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: Observations from the VERTIS CV trial. Diabetes, obesity & metabolism 26 (8) (2024)
Francesco Cosentino, Christopher Paul Cannon, Nikolaus Marx
The year in cardiovascular medicine 2023: the top 10 papers in diabetes and metabolic disorders. European heart journal (2024)
Markus Wallner, Mattia Emanuele Biber, Davide Stolfo, Gianfranco Sinagra, Lina Benson, Ulf Dahlström, Soffia Gudbjörnsdottir, Francesco Cosentino, Peter G M Mol, Giuseppe M C Rosano, Javed Butler, Marco Metra, Lars H Lund, Giulia Ferrannini, Gianluigi Savarese
Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes: data from the Swedish Heart Failure and Swedish National Diabetes Registries. European heart journal. Cardiovascular pharmacotherapy 10 (4) (2024)
Triantafyllos Chavakis, Francesco Cosentino, Ann Marie Schmidt
Cardiometabolic disease: linking pathogenic mechanisms to therapeutic opportunities. Cardiovascular research 119 (18) (2024)
Triantafyllos Chavakis, Francesco Cosentino, Ann Marie Schmidt
Cardiometabolic disease: linking pathogenic mechanisms to therapeutic opportunities. Cardiovascular research 119 (18) (2024)
Markus Wallner, Mattia Emanuele Biber, Davide Stolfo, Gianfranco Sinagra, Lina Benson, Ulf Dahlström, Soffia Gudbjörnsdottir, Francesco Cosentino, Peter G M Mol, Giuseppe M C Rosano, Javed Butler, Marco Metra, Lars H Lund, Giulia Ferrannini, Gianluigi Savarese
Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes: data from the Swedish Heart Failure and Swedish National Diabetes Registries. European heart journal. Cardiovascular pharmacotherapy 10 (4) (2024)
Triantafyllos Chavakis, Francesco Cosentino, Ann Marie Schmidt
Cardiometabolic disease: linking pathogenic mechanisms to therapeutic opportunities. Cardiovascular research (2024)
Francesco Cosentino, Christopher Paul Cannon, Nikolaus Marx
The year in cardiovascular medicine 2023: the top 10 papers in diabetes and metabolic disorders. European heart journal 45 (14) (2024)
Markus Wallner, Mattia Emanuele Biber, Davide Stolfo, Gianfranco Sinagra, Lina Benson, Ulf Dahlström, Soffia Gudbjörnsdottir, Francesco Cosentino, Peter G M Mol, Giuseppe M C Rosano, Javed Butler, Marco Metra, Lars H Lund, Giulia Ferrannini, Gianluigi Savarese
Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes: data from the Swedish Heart Failure and Swedish National Diabetes Registries. European heart journal. Cardiovascular pharmacotherapy 10 (4) (2024)
Ayodele Odutayo, Francesco Cosentino, Richard E Pratley, Samuel Dagogo-Jack, Darren K McGuire, Robert Frederich, Wei Fu, Christopher P Cannon, David Z I Cherney, null null
Hypoglycaemia and kidney events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: Observations from the VERTIS CV trial. Diabetes, obesity & metabolism (2024)
Francesco Cosentino, Christopher Paul Cannon, Nikolaus Marx
The year in cardiovascular medicine 2023: the top 10 papers in diabetes and metabolic disorders. European heart journal 45 (14) (2024)
Markus Wallner, Mattia Emanuele Biber, Davide Stolfo, Gianfranco Sinagra, Lina Benson, Ulf Dahlström, Soffia Gudbjörnsdottir, Francesco Cosentino, Peter G M Mol, Giuseppe M C Rosano, Javed Butler, Marco Metra, Lars H Lund, Giulia Ferrannini, Gianluigi Savarese
Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes. Data from the Swedish Heart Failure and Swedish National Diabetes Registries. European heart journal. Cardiovascular pharmacotherapy (2024)
Mahmoud Ibrahim, Ebtesam M Ba-Essa, Jason Baker, Avivit Cahn, Antonio Ceriello, Francesco Cosentino, Melanie Jane Davies, Robert H Eckel, Luc Van Gaal, Peter Haulund Gaede, Yehuda Handelsman, Samuel Klein, Richard David Leslie, Paolo Pozzilli, Stephano Del Prato, Francesco Prattichizzo, Oliver Schnell, Petar M Seferović, Eberhard Standl, Abraham Thomas, Jaakko Tuomilehto, Paul Valensi, Guillermo E Umpierrez
Cardio-renal-metabolic disease in primary care setting. Diabetes/metabolism research and reviews (2023)
Joseph M Kim, Deepak L Bhatt, Samuel Dagogo-Jack, David Z I Cherney, Francesco Cosentino, Darren K McGuire, Richard E Pratley, Chih-Chin Liu, Nilo B Cater, Robert C Frederich, James P Mancuso, Christopher P Cannon
Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease. Diabetes, obesity & metabolism (2023)
Arjun K Pandey, Deepak L Bhatt, Avinash Pandey, Nikolaus Marx, Francesco Cosentino, Ambarish Pandey, Subodh Verma
Mechanisms of benefits of sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction. European heart journal (2023)
Ambarish Pandey, Ahmed A Kolkailah, Francesco Cosentino, Christopher P Cannon, Robert C Frederich, David Z I Cherney, Samuel Dagogo-Jack, Richard E Pratley, Nilo B Cater, Ira Gantz, James P Mancuso, Darren K McGuire
Ertugliflozin and hospitalization for heart failure across the spectrum of pre-trial ejection fraction: post-hoc analyses of the VERTIS CV trial. European heart journal (2023)
Samuel Dagogo-Jack, Robert Frederich, Jie Liu, Christopher P Cannon, Harry Shi, David Z I Cherney, Francesco Cosentino, Urszula Masiukiewicz, Ira Gantz, Richard E Pratley
Ertugliflozin Delays Insulin Initiation and Reduces Insulin Dose Requirements in Patients With Type 2 Diabetes: Analyses From VERTIS CV. The Journal of clinical endocrinology and metabolism (2023)
Mahmoud Ibrahim, Ebtesam M Ba-Essa, Jason Baker, Avivit Cahn, Antonio Ceriello, Francesco Cosentino, Melanie Jane Davies, Robert H Eckel, Luc Van Gaal, Peter Haulund Gaede, Yehuda Handelsman, Samuel Klein, Richard David Leslie, Paolo Pozzilli, Stephano Del Prato, Francesco Prattichizzo, Oliver Schnell, Petar M Seferović, Eberhard Standl, Abraham Thomas, Jaakko Tuomilehto, Paul Valensi, Guillermo E Umpierrez
Cardio-renal-metabolic disease in primary care setting. Diabetes/metabolism research and reviews 40 (3) (2023)
Mahmoud Ibrahim, Ebtesam M Ba-Essa, Jason Baker, Avivit Cahn, Antonio Ceriello, Francesco Cosentino, Melanie Jane Davies, Robert H Eckel, Luc Van Gaal, Peter Haulund Gaede, Yehuda Handelsman, Samuel Klein, Richard David Leslie, Paolo Pozzilli, Stephano Del Prato, Francesco Prattichizzo, Oliver Schnell, Petar M Seferović, Eberhard Standl, Abraham Thomas, Jaakko Tuomilehto, Paul Valensi, Guillermo E Umpierrez
Cardio-renal-metabolic disease in primary care setting. Diabetes/metabolism research and reviews 40 (3) (2023)
Francesco Cosentino, Nikolaus Marx, Subodh Verma
The year in cardiovascular medicine 2022: the top 10 papers in diabetes and metabolic disorders. European heart journal 44 (6) (2023)
Samuel Dagogo-Jack, Robert Frederich, Jie Liu, Christopher P Cannon, Harry Shi, David Z I Cherney, Francesco Cosentino, Urszula Masiukiewicz, Ira Gantz, Richard E Pratley
Ertugliflozin Delays Insulin Initiation and Reduces Insulin Dose Requirements in Patients With Type 2 Diabetes: Analyses From VERTIS CV. The Journal of clinical endocrinology and metabolism (2023)
Francesco Cosentino, Nikolaus Marx, Subodh Verma
The year in cardiovascular medicine 2022: the top 10 papers in diabetes and metabolic disorders. European heart journal (2023)
Francesco Cosentino, Subodh Verma, Philip Ambery, Marianne Bach Treppendahl, Martin van Eickels, Stefan D Anker, Michele Cecchini, Paola Fioretto, Per-Henrik Groop, David Hess, Kamlesh Khunti, Carolyn Su Ping Lam, Isabelle Richard-Lordereau, Lars H Lund, Paul McGreavy, Philip N Newsome, Naveed Sattar, Scott Solomon, Franz Weidinger, Faiez Zannad, Andreas Zeiher
Cardiometabolic risk management: insights from a European Society of Cardiology Cardiovascular Round Table. European heart journal (2023)
Mahmoud Ibrahim, Ebtesam M Ba-Essa, Jason Baker, Avivit Cahn, Antonio Ceriello, Francesco Cosentino, Melanie Jane Davies, Robert H Eckel, Luc Van Gaal, Peter Haulund Gaede, Yehuda Handelsman, Samuel Klein, Richard David Leslie, Paolo Pozzilli, Stephano Del Prato, Francesco Prattichizzo, Oliver Schnell, Petar M Seferović, Eberhard Standl, Abraham Thomas, Jaakko Tuomilehto, Paul Valensi, Guillermo E Umpierrez
Cardio-renal-metabolic disease in primary care setting. Diabetes/metabolism research and reviews 40 (3) (2023)
Mahmoud Ibrahim, Ebtesam M Ba-Essa, Jason Baker, Avivit Cahn, Antonio Ceriello, Francesco Cosentino, Melanie Jane Davies, Robert H Eckel, Luc Van Gaal, Peter Haulund Gaede, Yehuda Handelsman, Samuel Klein, Richard David Leslie, Paolo Pozzilli, Stephano Del Prato, Francesco Prattichizzo, Oliver Schnell, Petar M Seferović, Eberhard Standl, Abraham Thomas, Jaakko Tuomilehto, Paul Valensi, Guillermo E Umpierrez
Cardio-renal-metabolic disease in primary care setting. Diabetes/metabolism research and reviews 40 (3) (2023)
Mahmoud Ibrahim, Ebtesam M Ba-Essa, Jason Baker, Avivit Cahn, Antonio Ceriello, Francesco Cosentino, Melanie Jane Davies, Robert H Eckel, Luc Van Gaal, Peter Haulund Gaede, Yehuda Handelsman, Samuel Klein, Richard David Leslie, Paolo Pozzilli, Stephano Del Prato, Francesco Prattichizzo, Oliver Schnell, Petar M Seferović, Eberhard Standl, Abraham Thomas, Jaakko Tuomilehto, Paul Valensi, Guillermo E Umpierrez
Cardio-renal-metabolic disease in primary care setting. Diabetes/metabolism research and reviews 40 (3) (2023)
Arjun K Pandey, Deepak L Bhatt, Francesco Cosentino, Nikolaus Marx, Ori Rotstein, Bertram Pitt, Ambarish Pandey, Javed Butler, Subodh Verma
Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease. European heart journal 43 (31) (2022)
Giulia Ferrannini, Francesco Cosentino
SGLT2i: new perspectives in diabetes and kidney disease. European heart journal. Cardiovascular pharmacotherapy 7 (3) (2022)
Giulia Ferrannini, Lars H Lund, Lina Benson, Manfredi Rizzo, Wael Almahmeed, Giuseppe M C Rosano, Gianluigi Savarese, Francesco Cosentino
Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: a nationwide registry analysis. European heart journal. Cardiovascular pharmacotherapy (2022)
Mathieu Kerneis, Francesco Cosentino, Roberto Ferrari, Jean-Louis Georges, Elena Kosmachova, Cécile Laroche, Aldo P Maggioni, Harald Rittger, Philippe Gabriel Steg, Justyna Maczynska, Luigi Tavazzi, Marco Valgimigli, Chris P Gale, Michel Komajda, null null
Impact of chronic coronary syndromes on cardiovascular hospitalization and mortality: the ESC-EORP CICD-LT registry. European journal of preventive cardiology 29 (15) (2022)
Francesco Cosentino, Deepak L Bhatt, Nikolaus Marx, Subodh Verma
The year in cardiovascular medicine 2021: diabetes and metabolic disorders. European heart journal 43 (4) (2022)
Francesco Cosentino, Christopher P Cannon, Robert Frederich, David Z I Cherney, Samuel Dagogo-Jack, Richard E Pratley, James P Mancuso, Mario Maldonado, Nilo B Cater, Shuai Wang, Darren K McGuire
Cardiorenal Outcomes With Ertugliflozin by Baseline Metformin Use: Post Hoc Analyses of the VERTIS CV Trial. Circulation 146 (8) (2022)
Subodh Verma, Nitish K Dhingra, Arjun K Pandey, Francesco Cosentino
Emerging role for SGLT2 inhibitors in mitigating the risk of hyperkalaemia in heart failure. European heart journal 43 (31) (2022)
Ayodele Odutayo, Bruno R da Costa, Tiago V Pereira, Vinay Garg, Samir Iskander, Fatimah Roble, Rahim Lalji, Cesar A Hincapié, Aquila Akingbade, Myanca Rodrigues, Arnav Agarwal, Bishoy Lawendy, Pakeezah Saadat, Jacob A Udell, Francesco Cosentino, Peter J Grant, Subodh Verma, Peter Jüni
Sodium-Glucose Cotransporter 2 Inhibitors, All-Cause Mortality, and Cardiovascular Outcomes in Adults with Type 2 Diabetes: A Bayesian Meta-Analysis and Meta-Regression. Journal of the American Heart Association 10 (18) (2021)
David A Hess, Subodh Verma, Deepak L Bhatt, Ehab Bakbak, Daniella C Terenzi, Pankaj Puar, Francesco Cosentino
Vascular repair and regeneration in cardiometabolic diseases. European heart journal (2021)
Sarah Costantino, Francesco Paneni, Rodolfo Battista, Lorenzo Castello, Giuliana Capretti, Sergio Chiandotto, Luigi Tanese, Giulio Russo, Dario Pitocco, Gaetano A Lanza, Massimo Volpe, Thomas F Lüscher, Francesco Cosentino
Impact of Glycemic Variability on Chromatin Remodeling, Oxidative Stress, and Endothelial Dysfunction in Patients With Type 2 Diabetes and With Target HbA1c Levels. Diabetes 66 (9) (2017)